|
Cardiovascular disease is a global health problem with no geographic, gender, or socio-economic boundaries. Despite the tremendous advances recently made in cardiac care, including drugs, devices, and diagnostic innovation, many patients continue to die from heart disease or live with significant morbidity. Challenges for the next decade include health promotion and disease prevention, obesity and diabetes, and acute heart failure and cardiorenal disease. We must broaden our scope of intervention to emphasize and extend preventive strategies, and translate our innovations into actions through carefully designed health policy strategies. Genomic and proteomic biomarkers promise to improve early detection and risk stratification, leading to a more personalized approach to cardiovascular medicine.
This conference brings together the most exciting advances in cardiovascular disease and related cardiometabolic and cardiorenal medicine, from treatment to prevention, and innovation to application. The program is unique because of its translational theme. The global faculty and participating audience present the faces of cardiovascular medicine with a truly international perspective.
To enhance the learning experience, the meeting features lectures, panel discussion, problem-solving sessions and case presentations to foster interaction between the faculty and the participants. The workshops will be particularly valuable in translating theoretical concepts and guidelines to individual cases in practice. This year our participants will have the opportunity to present their research work in our poster sessions.
Upon completion of this program participants should be able to:
-
Choose effective imaging strategies for the assessment of ischemic disease and heart failure
-
Recognize moving targets in risk factor management and implement preventative cardiology recommendations and advocate health promotion
-
Review the latest guidelines and surrogate marker targets for diabetic heart disease
-
Better understand the pathophysiology and management of cardiorenal disease
-
Implement the latest rhythm and device strategies
-
Review the etiology and prevalence of cardiomyopathies and infectious heart disease and how to approach diagnostic and therapeutic challenges
-
Discuss new treatment therapies and recent scientific advancements in acute coronary syndrome and heart failure management
-
Discuss clinical practice guidelines, late breaking trials results and the impact on cardiovascular care
Who should Attend
Cardiovascular Specialists
Internists
Allied Health Professionals (ACNP, Nurses, Pharmacists)
Heart Failure Care Teams
Trainees
Interested Primary Care Providers
Program Directors
Peter P. Liu, MD, FRCPC, FACC
President of the International Society of Cardiomyopathy and Heart Failure
Professor, Department of Medicine, University of Toronto
Staff Cardiologist, Toronto General Hospital
Michael E. Farkouh, MD, MSc, FRCPC, FACC, FAHA
Director, Clinical Trials, Peter Munk Cardiac Centre
Chair, Research, Division of Cardiology, University of Toronto
|
